P3 Health Partners (PIII) analyst forecast and price target
Analyst forecast
Consensus of 2 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Hold | $14.00 from $3.00 | May 22, 2026 |
| Lake Street | Maintained | Buy | $14.00 from $4.00 | May 15, 2026 |
| TD Cowen | Maintained | Hold | $3.00 from $8.00 | Apr 2, 2026 |
| Lake Street | Maintained | Buy | $4.00 from $12.50 | Mar 27, 2026 |
| BTIG | — | Neutral | — | Dec 12, 2025 |
| Lake Street | Maintained | Buy | $12.50 from $20.00 | Nov 17, 2025 |
| Lake Street | Initiated Coverage | Buy | $20.00 | Aug 28, 2025 |
| TD Cowen | Maintained | Hold | $0.25 from $0.90 | Nov 20, 2024 |
| BTIG | Downgraded | Buy → Neutral | — | Apr 1, 2024 |
| BTIG | Initiated Coverage | Buy | $5.00 | Sep 1, 2023 |
Frequently asked questions
Is PIII a buy, sell, or hold?
Analysts covering P3 Health Partners currently average a Buy rating: 1 buy, 1 hold and 0 sell, from 2 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on PIII?
On May 22, 2026, TD Cowen maintained P3 Health Partners at Hold with a price target of $14.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.